Independent and combined effects of dietary weight loss and exercise on leukocyte telomere length in postmenopausal women

Obesity

Volumn 21, Issue 12, 2013, Pages

  Mason, Caitlin ^a   Risques, Rosa Ana ^b   Xiao, Liren ^a   Duggan, Catherine R ^a   Imayama, Ikuyo ^a   Campbell, Kristin L ^c   Kong, Angela ^d   Foster Schubert, Karen E ^b   Wang, C Y ^a   Alfano, Catherine M ^e   Blackburn, George L ^f   Rabinovitch, Peter S ^b   McTiernan, Anne ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AEROBIC EXERCISE; AGE; AGED; ARTICLE; BLOOD SAMPLING; BODY FAT DISTRIBUTION; BODY MASS; CALORIC RESTRICTION; COMPARATIVE STUDY; CONTROLLED STUDY; DNA EXTRACTION; EXERCISE INTENSITY; FEMALE; HUMAN; INTENTION TO TREAT ANALYSIS; LEUKOCYTE; MAJOR CLINICAL STUDY; MIDDLE AGED; OBESITY; OUTCOME ASSESSMENT; OXYGEN CONSUMPTION; POLYMERASE CHAIN REACTION; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; TELOMERE HOMEOSTASIS; TREATMENT DURATION; WEIGHT REDUCTION;

ADIPOSE TISSUE; AGED; BODY MASS INDEX; DIET, REDUCING; EXERCISE; FEMALE; HUMANS; LEUKOCYTES; MIDDLE AGED; OBESITY; OVERWEIGHT; POSTMENOPAUSE; TELOMERE; WEIGHT LOSS;

EID: 84889651405     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20509     Document Type: Article

References (34)

1. Blasco MA,. Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet 2005; 6: 611-622.
2. Aviv A,. Telomeres and human aging: facts and fibs. Sci Aging Knowledge Environ 2004; 2004: pe43.
3. Sanders JL, Fitzpatrick AL, Boudreau RM, et al. Leukocyte telomere length is associated with noninvasively measured age-related disease: The cardiovascular health study. J Gerontol 2012; 67: 409-416.
4. Brouilette SW, Moore JS, McMahon AD, et al. Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study. Lancet 2007; 369: 107-114.
5. Prescott J, Wentzensen IM, Savage SA, et al. Epidemiologic evidence for a role of telomere dysfunction in cancer etiology. Mutat Res 2012; 730: 75-84.
6. Honig LS, Kang MS, Schupf N, et al. Association of shorter leukocyte telomere repeat length with dementia and mortality. Arch Neurol 2012; 69: 1332-1339.
7. Willeit P, Willeit J, Kloss-Brandstatter A, et al. Fifteen-year follow-up of association between telomere length and incident cancer and cancer mortality. JAMA 2011; 306: 42-44.
8. von Zglinicki T,. Oxidative stress shortens telomeres. Trends Biochem Sci 2002; 27: 339-344.
9. Du M, Prescott J, Kraft P, et al. Physical activity, sedentary behavior, and leukocyte telomere length in women. Am J Epidemiol 2012; 175: 414-422.
10. Kim S, Parks CG, DeRoo LA, et al. Obesity and weight gain in adulthood and telomere length. Cancer Epidemiol Biomarkers Prevent 2009; 18: 816-820.
11. Lee M, Martin H, Firpo MA, et al. Inverse association between adiposity and telomere length: the Fels longitudinal study. Am J Hum Biol 2011; 23: 100-106.
12. Cassidy A, De Vivo I, Liu Y, et al. Associations between diet, lifestyle factors, and telomere length in women. Am J Clin Nutr 2010; 91: 1273-1280.
13. Nordfjall K, Eliasson M, Stegmayr B, et al. Telomere length is associated with obesity parameters but with a gender difference. Obesity 2008; 16: 2682-289.
14. Sun Q, Shi L, Prescott J, et al. Healthy lifestyle and leukocyte telomere length in US Women. PloS One 2012; 7: e38374.
15. Risques RA, Arbeev KG, Yashin AI, et al. Leukocyte telomere length is associated with disability in older U.S. population. J Am Geriatr Soc 2010; 58: 1289-1298.
16. Bekaert S, De Meyer T, Rietzschel ER, et al. Telomere length and cardiovascular risk factors in a middle-aged population free of overt cardiovascular disease. Aging Cell 2007; 6: 639-647.
17. LaRocca TJ, Seals DR, Pierce GL,. Leukocyte telomere length is preserved with aging in endurance exercise-trained adults and related to maximal aerobic capacity. Mech Ageing Dev 2010; 131: 165-167.
18. Foster-Schubert KE, Alfano CM, Duggan C, et al. Effect of diet and exercise, alone or combined, on weight and body composition in overweight-to-obese postmenopausal women. Obesity 2011; 20: 1628-1638.
19. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
20. Ryan DH, Espeland MA, Foster GD, et al. Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Controlled Clin Trials 2003; 24: 610-628.
21. Pate R, Blair S, Durstine J,. Guidelines for Exercise Testing and Prescription. Philadelphia, PA: Lea & Febinger; 1991. p 70-72.
22. Cawthon RM,. Telomere measurement by quantitative PCR. Nucleic Acids Res 2002; 30: e47.
23. Aviv A, Hunt SC, Lin J, et al. Impartial comparative analysis of measurement of leukocyte telomere length/DNA content by Southern blots and qPCR. Nucleic Acids Res 2011; 39: e134.
24. Rector RS, Warner SO, Liu Y, et al. Exercise and diet induced weight loss improves measures of oxidative stress and insulin sensitivity in adults with characteristics of the metabolic syndrome. Am J Physiol Endocrinol Metab 2007; 293: E500-E506.
25. Imayama I, Ulrich CM, Alfano CM, et al. Effects of a caloric restriction weight loss diet and exercise on inflammatory biomarkers in overweight/obese postmenopausal women: a randomized controlled trial. Cancer Res 2012; 72: 2314-2326.
26. Zittermann A, Frisch S, Berthold HK, et al. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 2009; 89: 1321-1327.
27. Gardner JP, Li S, Srinivasan SR, et al. Rise in insulin resistance is associated with escalated telomere attrition. Circulation 2005; 111: 2171-2177.
28. Farzaneh-Far R, Lin J, Epel E, et al. Telomere length trajectory and its determinants in persons with coronary artery disease: longitudinal findings from the heart and soul study. PloS One 2010; 5: e8612.
29. Hovatta I, de Mello VD, Kananen L, et al. Leukocyte telomere length in the Finnish Diabetes Prevention Study. PloS One 2012; 7: e34948.
30. Krauss J, Farzaneh-Far R, Puterman E, et al. Physical fitness and telomere length in patients with coronary heart disease: findings from the Heart and Soul Study. PloS One 2011; 6: e26983.
31. Svenson U, Nordfjall K, Baird D, et al. Blood cell telomere length is a dynamic feature. PloS One 2011; 6: e21485.
32. Blackburn EH, Greider CW, Henderson E, et al. Recognition and elongation of telomeres by telomerase. Genome Natl Res Council Canada 1989; 31: 553-560.
33. Ornish D, Lin J, Daubenmier J, et al. Increased telomerase activity and comprehensive lifestyle changes: a pilot study. Lancet Oncol 2008; 9: 1048-1057.
34. Epel E,. How »reversible» is telomeric aging? Cancer Prevent Res 2012; 5: 1163-1168.